Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T regulatory cells with or without rituximab for recent-onset type 1 diabetes
ISRCTN37116985Phase 2Completed
- Sponsor
- Medical University of Gdańsk
- Start
- Jun 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of umbilical cord blood regulatory T cells and rituximab in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Medical University of Gdańsk. Primary endpoints: Number of adverse effects, C-peptide level and 2 more. Started Jun 2015; status: completed.
02
Drugs
umbilical cord blood regulatory T cellsrituximab
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ISRCTN37116985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN37116985.